Epstein-Barr Virus Early RNA EBERISH In Situ Hybridization Test
Introduction
The Epstein-Barr Virus Early RNA EBERISH In Situ Hybridization Test is an essential diagnostic procedure used to identify the presence of Epstein-Barr virus (EBV) early RNA within tumor tissues. This test plays a significant role in the detection and management of EBV-associated malignancies, particularly in oncology. By understanding the viral activity in tumors, healthcare providers can make informed decisions regarding treatment and patient care.
What the Test Measures
This test specifically measures the presence of early RNA transcripts from the Epstein-Barr virus, which can indicate active viral replication within tumor cells. It is particularly relevant in cancers where EBV is known to contribute to tumorigenesis, such as nasopharyngeal carcinoma and certain lymphomas.
Who Should Consider This Test
Patients who may benefit from this test include those presenting with symptoms related to EBV-associated cancers, such as:
- Unexplained lymphadenopathy
- Persistent fever and night sweats
- Weight loss
- Fatigue
Furthermore, individuals with a known history of EBV infection or those at high risk for EBV-related malignancies should consider this test as part of their diagnostic evaluation.
Benefits of Taking the Test
- Provides critical information for the diagnosis of EBV-associated cancers.
- Helps oncologists tailor treatment strategies based on viral activity.
- Facilitates early detection, which can improve patient outcomes.
- Offers insights into the prognosis and potential response to therapy.
Understanding Your Results
Results from the Epstein-Barr Virus Early RNA EBERISH In Situ Hybridization Test will indicate whether EBV early RNA is present in the tumor tissue. A positive result suggests active viral involvement, which may necessitate further evaluation and tailored treatment approaches. It is essential to discuss your results with your oncologist for comprehensive understanding and management.
Test Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| Epstein-Barr Virus Early RNA EBERISH In Situ Hybridization Test | 120,000 NGN | 160,000 NGN |
Booking the Test
If you are interested in the Epstein-Barr Virus Early RNA EBERISH In Situ Hybridization Test, please call or WhatsApp us at +2348077798758 to book your test today. Our team is ready to assist you with any questions and guide you through the process.
Turnaround Time: 10-12 days
Sample Type: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy, and Clinical history.
Pre-test Instructions: Please ensure to provide a copy of the Histopathology report, Site of biopsy, and Clinical history prior to the test.
